{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:53:57Z","timestamp":1779360837436,"version":"3.51.4"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11886-021-01551-x","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T14:02:49Z","timestamp":1627999369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications"],"prefix":"10.1007","volume":"23","author":[{"given":"Ossama K.","family":"Abou Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calvin C.","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom Kai Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-3306","authenticated-orcid":false,"given":"Paul C.","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"key":"1551_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0065-3527(08)60783-6","volume":"51","author":"SA Huber","year":"1998","unstructured":"Huber SA, Gauntt CJ, Sakkinen P. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv Virus Res [Internet]. 1998;51:35\u201380 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9891585.","journal-title":"Adv Virus Res [Internet]"},{"key":"1551_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1073\/pnas.89.1.314","volume":"89","author":"K Klingel","year":"1992","unstructured":"Klingel K, Hohenadl C, Canu A, Albrecht M, Seemann M, Mall G, et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A [Internet]. 1992;89:314\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1309611.","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"key":"1551_CR3","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/1357-4310(96)81799-0","volume":"2","author":"S Malkiel","year":"1996","unstructured":"Malkiel S, Kuan AP, Diamond B. Autoimmunity in heart disease: mechanisms and genetic susceptibility. Mol Med Today [Internet]. 1996;2:336\u201342 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8796919.","journal-title":"Mol Med Today [Internet]"},{"key":"1551_CR4","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","volume":"28","author":"ALP Caforio","year":"2007","unstructured":"Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S, et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J [Internet]. 2007;28:1326\u201333 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17493945.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.108.769489","volume":"118","author":"I Kindermann","year":"2008","unstructured":"Kindermann I, Kindermann M, Kandolf R, Klingel K, B\u00fcltmann B, M\u00fcller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation [Internet]. 2008;118:639\u201348 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18645053.","journal-title":"Circulation [Internet]"},{"key":"1551_CR6","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/01.CIR.0000118493.13323.81","volume":"109","author":"H Mahrholdt","year":"2004","unstructured":"Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation [Internet]. 2004;109:1250\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14993139.","journal-title":"Circulation [Internet]"},{"key":"1551_CR7","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMc0911362","volume":"362","author":"C-T Bock","year":"2010","unstructured":"Bock C-T, Klingel K, Kandolf R. Human parvovirus B19-associated myocarditis. N Engl J Med [Internet]. 2010;362:1248\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20357294.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR8","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/hrt.78.6.539","volume":"78","author":"C Baboonian","year":"1997","unstructured":"Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart Int. 1997;78:539\u201343 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9470867.","journal-title":"Heart Int"},{"key":"1551_CR9","first-page":"135","volume":"88","author":"B Maisch","year":"1993","unstructured":"Maisch B, Sch\u00f6nian U, Crombach M, Wendl I, Bethge C, Herzum M, et al. Cytomegalovirus associated inflammatory heart muscle disease. Scand J Infect Dis Suppl [Internet]. 1993;88:135\u201348 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8390717.","journal-title":"Scand J Infect Dis Suppl [Internet]"},{"key":"1551_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/01.CIR.0000155616.07901.35","volume":"111","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \u201cidiopathic\u201d left ventricular dysfunction. Circulation [Internet]. 2005;111:887\u201393 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15699250.","journal-title":"Circulation [Internet]"},{"key":"1551_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-4615-2996-5_56","volume":"342","author":"LK Alexander","year":"1993","unstructured":"Alexander LK, Keene BW, Small JD, Yount B, Baric RS. Electrocardiographic changes following rabbit coronavirus-induced myocarditis and dilated cardiomyopathy. Adv Exp Med Biol [Internet]. 1993;342:365\u201370 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8209755.","journal-title":"Adv Exp Med Biol [Internet]"},{"key":"1551_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","unstructured":"CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020;69:343\u20136 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32214079.","journal-title":"MMWR Morb Mortal Wkly Rep [Internet]"},{"key":"1551_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol [Internet]. 2020;5:802\u201310 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32211816.","journal-title":"JAMA Cardiol [Internet]"},{"key":"1551_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020;5:811\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32219356.","journal-title":"JAMA Cardiol [Internet]"},{"key":"1551_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","volume":"5","author":"D Atri","year":"2020","unstructured":"Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies. JACC Basic to Transl Sci [Internet]. 2020;5:518\u201336 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32292848.","journal-title":"JACC Basic to Transl Sci [Internet]"},{"key":"1551_CR16","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","volume":"126","author":"A Akhmerov","year":"2020","unstructured":"Akhmerov A, Marb\u00e1n E. COVID-19 and the Heart. Circ Res [Internet]. 2020;126:1443\u201355 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32252591.","journal-title":"Circ Res [Internet]"},{"key":"1551_CR17","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/eurheartj\/ehaa462","volume":"41","author":"JM Peric\u00e0s","year":"2020","unstructured":"Peric\u00e0s JM, Hernandez-Meneses M, Sheahan TP, Quintana E, Ambrosioni J, Sandoval E, et al. COVID-19: from epidemiology to treatment. Eur Heart J [Internet]. 2020;41:2092\u2013112 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32511724.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR18","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cardfail.2020.04.009","volume":"26","author":"G Tersalvi","year":"2020","unstructured":"Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms. J Card Fail [Internet]. 2020;26:470\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32315733.","journal-title":"J Card Fail [Internet]"},{"key":"1551_CR19","unstructured":"RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med [Internet]. 2020; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32678530."},{"key":"1551_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med [Internet]. 2020;383:1813\u201326 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32445440.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","volume":"93","author":"P Richardson","year":"1996","unstructured":"Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O\u2019Connell J, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation [Internet]. 1996;93:841\u20132 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8598070.","journal-title":"Circulation [Internet]"},{"key":"1551_CR22","first-page":"3","volume":"1","author":"HT Aretz","year":"1987","unstructured":"Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol [Internet]. 1987;1:3\u201314 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3455232.","journal-title":"Am J Cardiovasc Pathol [Internet]"},{"key":"1551_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0025-6196(12)61286-5","volume":"64","author":"AJ Hauck","year":"1989","unstructured":"Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc [Internet]. 1989;64:1235\u201345 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2593714.","journal-title":"Mayo Clin Proc [Internet]"},{"key":"1551_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0735-1097(89)90465-8","volume":"14","author":"LH Chow","year":"1989","unstructured":"Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol [Internet]. 1989;14:915\u201320 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2794278.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR25","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4065\/76.10.1030","volume":"76","author":"LA Wu","year":"2001","unstructured":"Wu LA, Lapeyre AC, Cooper LT. Current role of endomyocardial biopsy in the management of dilated cardiomyopathy and myocarditis. Mayo Clin Proc [Internet]. 2001;76:1030\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11605687.","journal-title":"Mayo Clin Proc [Internet]"},{"key":"1551_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1161\/CIRCULATIONAHA.105.589663","volume":"113","author":"KL Baughman","year":"2006","unstructured":"Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation [Internet]. 2006;113:593\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16449736.","journal-title":"Circulation [Internet]"},{"key":"1551_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM199508033330501","volume":"333","author":"JW Mason","year":"1995","unstructured":"Mason JW, O\u2019Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med [Internet]. 1995;333:269\u201375 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7596370.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR28","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"ALP Caforio","year":"2013","unstructured":"Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J [Internet]. 2013;34:2636\u201348 2648a-2648d. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23824828.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S0140-6736(11)60648-X","volume":"379","author":"S Sagar","year":"2012","unstructured":"Sagar S, Liu PP, Cooper LT. Myocarditis. Lancet (London, England) [Internet]. 2012;379:738\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22185868.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR30","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A a JACC White Paper. J Am Coll Cardiol [Internet]. 2009;53:1475\u201387 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19389557.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR31","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"\u2022\u2022 Ferreira VM, Schulz-Menger J, Holmvang G, Kramer CM, Carbone I, Sechtem U, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol [Internet]. 2018;72:3158\u201376 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30545455. Advances in CMR criteria for documenting myocarditis helps standardize the diagnosis of patients presenting with SARS-CoV-2 myocarditis.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jcmg.2011.11.022","volume":"5","author":"P Lurz","year":"2012","unstructured":"Lurz P, Eitel I, Adam J, Steiner J, Grothoff M, Desch S, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging [Internet]. 2012;5:513\u201324 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22595159.","journal-title":"JACC Cardiovasc Imaging [Internet]"},{"key":"1551_CR33","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.jacc.2016.02.013","volume":"67","author":"P Lurz","year":"2016","unstructured":"Lurz P, Luecke C, Eitel I, F\u00f6hrenbach F, Frank C, Grothoff M, et al. Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. J Am Coll Cardiol [Internet]. 2016;67:1800\u201311 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27081020.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR34","doi-asserted-by":"crossref","unstructured":"Schumm J, Greulich S, Wagner A, Gr\u00fcn S, Ong P, Bentz K, et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson [Internet]. 2014;(16):14 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24461053.","DOI":"10.1186\/1532-429X-16-14"},{"key":"1551_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jcmg.2016.01.010","volume":"9","author":"A Kadkhodayan","year":"2016","unstructured":"Kadkhodayan A, Chareonthaitawee P, Raman SV, Cooper LT. Imaging of Inflammation in Unexplained Cardiomyopathy. JACC Cardiovasc Imaging [Internet]. 2016;9:603\u201317 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27151523.","journal-title":"JACC Cardiovasc Imaging [Internet]"},{"key":"1551_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/ehjci\/jeu099","volume":"15","author":"E Vermes","year":"2014","unstructured":"Vermes E, Childs H, Faris P, Friedrich MG. Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. Eur Heart J Cardiovasc Imaging [Internet]. 2014;15:1140\u20134 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24925145.","journal-title":"Eur Heart J Cardiovasc Imaging [Internet]"},{"key":"1551_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejrad.2016.10.031","volume":"86","author":"S Bohnen","year":"2017","unstructured":"Bohnen S, Radunski UK, Lund GK, Tahir E, Avanesov M, Stehning C, et al. T1 mapping cardiovascular magnetic resonance imaging to detect myocarditis-Impact of slice orientation on the diagnostic performance. Eur J Radiol [Internet]. 2017;86:6\u201312 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28027767.","journal-title":"Eur J Radiol [Internet]"},{"key":"1551_CR38","doi-asserted-by":"crossref","first-page":"e005242","DOI":"10.1161\/CIRCIMAGING.116.005242","volume":"10","author":"F von Knobelsdorff-Brenkenhoff","year":"2017","unstructured":"von Knobelsdorff-Brenkenhoff F, Sch\u00fcler J, Dogang\u00fczel S, Dieringer MA, Rudolph A, Greiser A, et al. Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance. Circ Cardiovasc Imaging [Internet]. 2017;10:e005242 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28213448.","journal-title":"Circ Cardiovasc Imaging [Internet]"},{"key":"1551_CR39","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.jcmg.2017.12.008","volume":"11","author":"CP Kotanidis","year":"2018","unstructured":"Kotanidis CP, Bazmpani M-A, Haidich A-B, Karvounis C, Antoniades C, Karamitsos TD. Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. JACC Cardiovasc Imaging [Internet]. 2018;11:1583\u201390 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29454761.","journal-title":"JACC Cardiovasc Imaging [Internet]"},{"key":"1551_CR40","doi-asserted-by":"crossref","first-page":"e007598","DOI":"10.1161\/CIRCIMAGING.118.007598","volume":"11","author":"JA Pan","year":"2018","unstructured":"Pan JA, Lee YJ, Salerno M. Diagnostic Performance of Extracellular Volume, Native T1, and T2 Mapping Versus Lake Louise Criteria by Cardiac Magnetic Resonance for Detection of Acute Myocarditis: A Meta-Analysis. Circ Cardiovasc Imaging [Internet]. 2018;11:e007598 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30012826.","journal-title":"Circ Cardiovasc Imaging [Internet]"},{"key":"1551_CR41","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1093\/eurheartj\/ehr165","volume":"32","author":"H-P Schultheiss","year":"2011","unstructured":"Schultheiss H-P, K\u00fchl U, Cooper LT. The management of myocarditis. Eur Heart J [Internet]. 2011;32:2616\u201325 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21705357.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR42","first-page":"315","volume":"323","author":"KU Knowlton","year":"2008","unstructured":"Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol [Internet]. 2008;323:315\u201335 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18357777.","journal-title":"Curr Top Microbiol Immunol [Internet]"},{"key":"1551_CR43","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI1972","volume":"102","author":"R Wessely","year":"1998","unstructured":"Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest [Internet]. 1998;102:1444\u201353 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9769337.","journal-title":"J Clin Invest [Internet]"},{"key":"1551_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.001531","volume":"128","author":"M Imazio","year":"2013","unstructured":"Imazio M, Brucato A, Barbieri A, Ferroni F, Maestroni S, Ligabue G, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation [Internet]. 2013;128:42\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23709669.","journal-title":"Circulation [Internet]"},{"key":"1551_CR45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1161\/CIRCHEARTFAILURE.109.902833","volume":"3","author":"SR Foerster","year":"2010","unstructured":"Foerster SR, Canter CE, Cinar A, Sleeper LA, Webber SA, Pahl E, et al. Ventricular remodeling and survival are more favorable for myocarditis than for idiopathic dilated cardiomyopathy in childhood: an outcomes study from the Pediatric Cardiomyopathy Registry. Circ Heart Fail [Internet]. 2010;3:689\u201397 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20833772.","journal-title":"Circ Heart Fail [Internet]"},{"key":"1551_CR46","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.110.973826","volume":"124","author":"JA Alvarez","year":"2011","unstructured":"Alvarez JA, Orav EJ, Wilkinson JD, Fleming LE, Lee DJ, Sleeper LA, et al. Competing risks for death and cardiac transplantation in children with dilated cardiomyopathy: results from the pediatric cardiomyopathy registry. Circulation [Internet]. 2011;124:814\u201323 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21788591.","journal-title":"Circulation [Internet]"},{"key":"1551_CR47","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati E, Cipriani M, Moro C, Raineri C, Pini D, Sormani P, et al. Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry. Circulation [Internet]. 2018;138:1088\u201399 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29764898.","journal-title":"Circulation [Internet]"},{"key":"1551_CR48","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/oxfordjournals.eurheartj.a015230","volume":"18","author":"AL Caforio","year":"1997","unstructured":"Caforio AL, Goldman JH, Haven AJ, Baig KM, Libera LD, McKenna WJ. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. Eur Heart J [Internet]. 1997;18:270\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9043844.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0735-1097(99)00485-4","volume":"35","author":"B Lauer","year":"2000","unstructured":"Lauer B, Schannwell M, K\u00fchl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol [Internet]. 2000;35:11\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10636253.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/08916930802031546","volume":"41","author":"ALP Caforio","year":"2008","unstructured":"Caforio ALP, Vinci A, Iliceto S. Anti-heart autoantibodies in familial dilated cardiomyopathy. Autoimmunity [Internet]. 2008;41:462\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18781472.","journal-title":"Autoimmunity [Internet]"},{"key":"1551_CR51","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper","year":"2009","unstructured":"Cooper LT. Myocarditis. N Engl J Med [Internet]. 2009;360:1526\u201338 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19357408.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR52","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","volume":"112","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation [Internet]. 2005;112:1965\u201370 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16172268.","journal-title":"Circulation [Internet]"},{"key":"1551_CR53","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jacc.2012.01.007","volume":"59","author":"S Gr\u00fcn","year":"2012","unstructured":"Gr\u00fcn S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol [Internet]. 2012;59:1604\u201315 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22365425.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR54","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/jmri.24504","volume":"40","author":"G Barone-Rochette","year":"2014","unstructured":"Barone-Rochette G, Augier C, Rodi\u00e8re M, Quesada J-L, Foote A, Bouvaist H, et al. Potentially simple score of late gadolinium enhancement cardiac MR in acute myocarditis outcome. J Magn Reson Imaging [Internet]. 2014;40:1347\u201354 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24293405.","journal-title":"J Magn Reson Imaging [Internet]"},{"key":"1551_CR55","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","volume":"70","author":"C Gr\u00e4ni","year":"2017","unstructured":"Gr\u00e4ni C, Eichhorn C, Bi\u00e8re L, Murthy VL, Agarwal V, Kaneko K, et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol [Internet]. 2017;70:1964\u201376 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29025553.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR56","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/0002-8703(90)90251-R","volume":"120","author":"S Rezkalla","year":"1990","unstructured":"Rezkalla S, Kloner RA, Khatib G, Khatib R. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis. Am Heart J [Internet]. 1990;120:1377\u201381 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2174203.","journal-title":"Am Heart J [Internet]"},{"key":"1551_CR57","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/01.CIR.83.6.2021","volume":"83","author":"M Tominaga","year":"1991","unstructured":"Tominaga M, Matsumori A, Okada I, Yamada T, Kawai C. Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. Circulation [Internet]. 1991;83:2021\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1674900.","journal-title":"Circulation [Internet]"},{"key":"1551_CR58","first-page":"351979","volume":"2012","author":"A Ukimura","year":"2012","unstructured":"Ukimura A, Satomi H, Ooi Y, Kanzaki Y. Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res Treat [Internet]. 2012;2012:351979 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23304476.","journal-title":"Influenza Res Treat [Internet]"},{"key":"1551_CR59","first-page":"411","volume":"37","author":"NR Rose","year":"1992","unstructured":"Rose NR, Neumann DA, Herskowitz A. Coxsackievirus myocarditis. Adv Intern Med [Internet]. 1992;37:411\u201329 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1558005.","journal-title":"Adv Intern Med [Internet]"},{"key":"1551_CR60","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/0735-1097(88)92618-6","volume":"12","author":"C Kishimoto","year":"1988","unstructured":"Kishimoto C, Crumpacker CS, Abelmann WH. Ribavirin treatment of murine coxsackievirus B3 myocarditis with analyses of lymphocyte subsets. J Am Coll Cardiol [Internet]. 1988;12:1334\u201341 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2844874.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR61","doi-asserted-by":"crossref","unstructured":"Kishimoto C, Crumpacker CS, Abelmann WH. Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon alpha A\/D, Cardiovasc Res [Internet]. 1988;22:732\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2855719.","DOI":"10.1093\/cvr\/22.10.732"},{"key":"1551_CR62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/0002-8703(88)90013-0","volume":"115","author":"A Matsumori","year":"1988","unstructured":"Matsumori A, Tomioka N, Kawai C. Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J [Internet]. 1988;115:1229\u201332 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2837073.","journal-title":"Am Heart J [Internet]"},{"key":"1551_CR63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2014.10.165","volume":"179","author":"ALP Caforio","year":"2015","unstructured":"Caforio ALP, Angelini A, Blank M, Shani A, Kivity S, Goddard G, et al. Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice. Int J Cardiol [Internet]. 2015;179:166\u201377 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25464438.","journal-title":"Int J Cardiol [Internet]"},{"key":"1551_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2180-3-25","volume":"3","author":"E Padalko","year":"2003","unstructured":"Padalko E, Verbeken E, Matthys P, Aerts JL, De Clercq E, Neyts J. Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice. BMC Microbiol [Internet]. 2003;3:25 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14687413.","journal-title":"BMC Microbiol [Internet]"},{"key":"1551_CR65","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0735-1097(86)80349-7","volume":"7","author":"N Tomioka","year":"1986","unstructured":"Tomioka N, Kishimoto C, Matsumori A, Kawai C. Effects of prednisolone on acute viral myocarditis in mice. J Am Coll Cardiol [Internet]. 1986;7:868\u201372 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3007597.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR66","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/01.CIR.73.5.1058","volume":"73","author":"ES Monrad","year":"1986","unstructured":"Monrad ES, Matsumori A, Murphy JC, Fox JG, Crumpacker CS, Abelmann WH. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. Circulation [Internet]. 1986;73:1058\u201364 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3698228.","journal-title":"Circulation [Internet]"},{"key":"1551_CR67","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/07315724.1991.10718176","volume":"10","author":"RS London","year":"1991","unstructured":"London RS, Bradley L, Chiamori NY. Effect of a nutritional supplement on premenstrual symptomatology in women with premenstrual syndrome: a double-blind longitudinal study. J Am Coll Nutr [Internet]. 1991;10:494\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1955626.","journal-title":"J Am Coll Nutr [Internet]"},{"key":"1551_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/01.CIR.104.1.39","volume":"104","author":"R Wojnicz","year":"2001","unstructured":"Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation [Internet]. 2001;104:39\u201345 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11435335.","journal-title":"Circulation [Internet]"},{"key":"1551_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2261-5-12","volume":"5","author":"JL Robinson","year":"2005","unstructured":"Robinson JL, Hartling L, Crumley E, Vandermeer B, Klassen TP. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord [Internet]. 2005;5:12 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15932639.","journal-title":"BMC Cardiovasc Disord [Internet]"},{"key":"1551_CR70","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/pgmj.2005.037515","volume":"82","author":"C-M Yu","year":"2006","unstructured":"Yu C-M, Wong RS-M, Wu EB, Kong S-L, Wong J, Yip GW-K, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J [Internet]. 2006;82:140\u20134 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16461478.","journal-title":"Postgrad Med J [Internet]"},{"key":"1551_CR71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","volume":"36","author":"T Alhogbani","year":"2016","unstructured":"Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med [Internet]. 2016;36:78\u201380 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26922692.","journal-title":"Ann Saudi Med [Internet]"},{"key":"1551_CR72","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA [Internet]. 2020;323:1061\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32031570.","journal-title":"JAMA [Internet]"},{"key":"1551_CR73","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","volume":"76","author":"A Lala","year":"2020","unstructured":"Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol [Internet]. 2020;76:533\u201346 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32517963.","journal-title":"J Am Coll Cardiol [Internet]"},{"key":"1551_CR74","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) [Internet]. 2020;395:497\u2013506 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31986264.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR75","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.recesp.2020.04.001","volume":"73","author":"\u00c1 Irabien-Ortiz","year":"2020","unstructured":"Irabien-Ortiz \u00c1, Carreras-Mora J, Sionis A, P\u00e0mies J, Montiel J, Tauron M. Fulminant myocarditis due to COVID-19. Rev Esp Cardiol (Engl Ed) [Internet]. 2020;73:503\u20134 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32345547.","journal-title":"Rev Esp Cardiol (Engl Ed) [Internet]"},{"key":"1551_CR76","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/ehjci\/jeaa107","volume":"21","author":"J-F Paul","year":"2020","unstructured":"Paul J-F, Charles P, Richaud C, Caussin C, Diakov C. Myocarditis revealing COVID-19 infection in a young patient. Eur Heart J Cardiovasc Imaging [Internet]. 2020;21:776 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32338706.","journal-title":"Eur Heart J Cardiovasc Imaging [Internet]"},{"key":"1551_CR77","first-page":"e20201509","volume":"146","author":"D Lara","year":"2020","unstructured":"Lara D, Young T, Del Toro K, Chan V, Ianiro C, Hunt K, et al. Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection. Pediatr Int. 2020;146:e20201509 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32747591.","journal-title":"Pediatr Int"},{"key":"1551_CR78","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf.1828","volume":"22","author":"G Tavazzi","year":"2020","unstructured":"Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail [Internet]. 2020;22:911\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32275347.","journal-title":"Eur J Heart Fail [Internet]"},{"key":"1551_CR79","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","volume":"33","author":"S Tian","year":"2020","unstructured":"Tian S, Xiong Y, Liu H, Niu L, Guo J, Liao M, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol [Internet]. 2020;33:1007\u201314 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32291399.","journal-title":"Mod Pathol [Internet]"},{"key":"1551_CR80","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","volume":"153","author":"LM Barton","year":"2020","unstructured":"Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol [Internet]. 2020;153:725\u201333 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32275742.","journal-title":"Am J Clin Pathol [Internet]"},{"key":"1551_CR81","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England) [Internet]. 2020;395:1417\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32325026.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR82","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med [Internet]. 2020;8:420\u20132 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32085846.","journal-title":"Lancet Respir Med [Internet]"},{"key":"1551_CR83","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","volume":"5","author":"D Lindner","year":"2020","unstructured":"Lindner D, Fitzek A, Br\u00e4uninger H, Aleshcheva G, Edler C, Meissner K, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol [Internet]. 2020;5:1281\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32730555.","journal-title":"JAMA Cardiol [Internet]"},{"key":"1551_CR84","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/ehf2.12805","volume":"7","author":"F Escher","year":"2020","unstructured":"Escher F, Pietsch H, Aleshcheva G, Bock T, Baumeier C, Elsaesser A, et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Hear Fail [Internet]. 2020;7:2440\u20137 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32529795.","journal-title":"ESC Hear Fail [Internet]"},{"key":"1551_CR85","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.120.049465","volume":"142","author":"SE Fox","year":"2020","unstructured":"\u2022 Fox SE, Li G, Akmatbekov A, Harbert JL, Lameira FS, Brown JQ, et al. Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation [Internet]. 2020;142:1123\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32689809. SARS-CoV-2 tropism to cardiac pericytes and endothelial cells has been documented further supporting myocardial injury in patients presenting with myocarditis picture.","journal-title":"Circulation [Internet]"},{"key":"1551_CR86","doi-asserted-by":"publisher","unstructured":"Chen S, Yang L, Nilsson-Payant B, Han Y, Jaffr\u00e9 F, Zhu J, et al. SARS-CoV-2 infected cardiomyocytes recruit monocytes by secreting CCL2. Res Sq [Preprint]. 2020 Nov 17:rs.3.rs-94634. https:\/\/doi.org\/10.21203\/rs.3.rs-94634\/v1.","DOI":"10.21203\/rs.3.rs-94634\/v1"},{"key":"1551_CR87","doi-asserted-by":"publisher","unstructured":"P\u00e9rez-Bermejo JA, Kang S, Rockwood SJ, Simoneau CR, Joy DA, Ramadoss GN, et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. bioRxiv [Preprint]. 2020 Sep 12:2020.08.25.265561. https:\/\/doi.org\/10.1101\/2020.08.25.265561 Update in: Sci Transl Med. 2021 Mar 15.","DOI":"10.1101\/2020.08.25.265561"},{"key":"1551_CR88","first-page":"411","volume":"49","author":"XH Yao","year":"2020","unstructured":"Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua bing li xue za zhi = Chinese J Pathol [Internet]. 2020;49:411\u20137 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32172546.","journal-title":"Zhonghua bing li xue za zhi = Chinese J Pathol [Internet]"},{"key":"1551_CR89","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","volume":"41","author":"S Sala","year":"2020","unstructured":"Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J [Internet]. 2020;41:1861\u20132 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32267502.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR90","doi-asserted-by":"publisher","unstructured":"Clark DE, Parikh A, Dendy JM, Diamond AB, George-Durrett K, Fish FA, et al. COVID-19 myocardial pathology evaluated through scrEening cardiac magnetic resonance (COMPETE CMR). medRxiv [Preprint]. 2020 Sep 2:2020.08.31.20185140. https:\/\/doi.org\/10.1101\/2020.08.31.20185140 Update in: Circulation. 2020 Dec 17.","DOI":"10.1101\/2020.08.31.20185140"},{"key":"1551_CR91","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/CIRCULATIONAHA.120.049252","volume":"142","author":"DS Knight","year":"2020","unstructured":"Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, et al. COVID-19: Myocardial Injury in Survivors. Circulation [Internet]. 2020;142:1120\u20132 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32673505.","journal-title":"Circulation [Internet]"},{"key":"1551_CR92","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020;5:1265\u201373 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32730619.","journal-title":"JAMA Cardiol [Internet]"},{"key":"1551_CR93","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1097\/INF.0000000000002788","volume":"39","author":"B Trogen","year":"2020","unstructured":"Trogen B, Gonzalez FJ, Shust GF. COVID-19-Associated Myocarditis in an Adolescent. Pediatr Infect Dis J [Internet]. 2020;39:e204\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32502128.","journal-title":"Pediatr Infect Dis J [Internet]"},{"key":"1551_CR94","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/S0140-6736(20)30912-0","volume":"395","author":"D Doyen","year":"2020","unstructured":"Doyen D, Moceri P, Ducreux D, Dellamonica J. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet (London, England) [Internet]. 2020;395:1516 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32334650.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR95","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","volume":"5","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020;5:819\u201324 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32219357.","journal-title":"JAMA Cardiol [Internet]"},{"key":"1551_CR96","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","volume":"41","author":"I-C Kim","year":"2020","unstructured":"Kim I-C, Kim JY, Kim HA, Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J [Internet]. 2020;41:1859 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32282027.","journal-title":"Eur Heart J [Internet]"},{"key":"1551_CR97","doi-asserted-by":"crossref","first-page":"e003603","DOI":"10.1161\/JAHA.116.003603","volume":"5","author":"JA Luetkens","year":"2016","unstructured":"Luetkens JA, Homsi R, Dabir D, Kuetting DL, Marx C, Doerner J, et al. Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute Myocarditis. J Am Heart Assoc [Internet]. 2016;5:e003603 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27436306.","journal-title":"J Am Heart Assoc [Internet]"},{"key":"1551_CR98","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","volume":"196","author":"ACB Lemos","year":"2020","unstructured":"Lemos ACB, do Esp\u00edrito Santo DA, Salvetti MC, Gilio RN, Agra LB, Pazin-Filho A, et al. Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID). Thromb Res [Internet]. 2020;196:359\u201366 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32977137.","journal-title":"Thromb Res [Internet]"},{"key":"1551_CR99","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res [Internet]. 2020;30:269\u201371 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32020029.","journal-title":"Cell Res [Internet]"},{"key":"1551_CR100","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (London, England) [Internet]. 2020;395:1569\u201378 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32423584.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR101","doi-asserted-by":"publisher","first-page":"209","DOI":"10.7326\/M20-5752","volume":"174","author":"TJ Wilt","year":"2021","unstructured":"Wilt TJ, Kaka AS, MacDonald R, Greer N, Obley A, Duan-Porter W. Remdesivir for Adults With COVID-19\u00a0: A Living Systematic Review for American College of Physicians Practice Points. Ann Intern Med [Internet]. 2021;174:209\u201320 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33017170.","journal-title":"Ann Intern Med [Internet]"},{"key":"1551_CR102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"H Pan","year":"2021","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo A-M, Preziosi M-P, Sathiyamoorthy V, et al. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med [Internet]. 2021;384:497\u2013511 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33264556.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR103","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/infdis\/jiaa350","volume":"222","author":"N Clementi","year":"2020","unstructured":"Clementi N, Ferrarese R, Criscuolo E, Diotti RA, Castelli M, Scagnolari C, et al. Interferon-\u03b2-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection. J Infect Dis [Internet]. 2020;222:722\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32559285.","journal-title":"J Infect Dis [Internet]"},{"key":"1551_CR104","first-page":"eabd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Forensic Sci Int. 2020;370:eabd4570 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32972995.","journal-title":"Forensic Sci Int"},{"key":"1551_CR105","first-page":"eabd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Forensic Sci Int. 2020;370:eabd4585 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32972996.","journal-title":"Forensic Sci Int"},{"key":"1551_CR106","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF-N Hung","year":"2020","unstructured":"Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, et al. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet (London, England) [Internet]. 2020;395:1695\u2013704 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32401715.","journal-title":"Lancet (London, England) [Internet]"},{"key":"1551_CR107","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","volume":"9","author":"PD Monk","year":"2021","unstructured":"\u2022 Monk PD, Marsden RJ, Tear VJ, Brookes J, Batten TN, Mankowski M, et al. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir Med [Internet]. 2021;9:196\u2013206 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33189161. Recombinant interferon use may present as a therapeutic opportunity in patients with SARS-CoV-2 infection and associated myocarditis akin to prior animal studies.","journal-title":"Lancet Respir Med [Internet]"},{"key":"1551_CR108","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/cid\/ciaa237","volume":"71","author":"X Yao","year":"2020","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis [Internet]. 2020;71:732\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32150618.","journal-title":"Clin Infect Dis [Internet]"},{"key":"1551_CR109","doi-asserted-by":"publisher","first-page":"m1849","DOI":"10.1136\/bmj.m1849","volume":"369","author":"W Tang","year":"2020","unstructured":"Tang W, Cao Z, Han M, Wang Z, Chen J, Sun W, et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ [Internet]. 2020;369:m1849 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32409561.","journal-title":"BMJ [Internet]"},{"key":"1551_CR110","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","volume":"383","author":"AB Cavalcanti","year":"2020","unstructured":"Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med [Internet]. 2020;383:2041\u201352 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32706953.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR111","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1001\/jama.2020.22240","volume":"324","author":"WH Self","year":"2020","unstructured":"Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, et al. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA [Internet]. 2020;324:2165\u201376 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33165621.","journal-title":"JAMA [Internet]"},{"key":"1551_CR112","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, et al. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA [Internet]. 2020;324:1317\u201329 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32876697.","journal-title":"JAMA [Internet]"},{"key":"1551_CR113","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","volume":"324","author":"P-F Dequin","year":"2020","unstructured":"Dequin P-F, Heming N, Meziani F, Plantef\u00e8ve G, Voiriot G, Badi\u00e9 J, et al. Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA [Internet]. 2020;324:1298\u2013306 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32876689.","journal-title":"JAMA [Internet]"},{"key":"1551_CR114","doi-asserted-by":"publisher","unstructured":"CMP J, MEL F, FFA V, Sampaio VS, MAA A, Melo GC, et al. Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial. Clin Infect Dis. 2021 May 4;72(9):e373\u201381. https:\/\/doi.org\/10.1093\/cid\/ciaa1177.","DOI":"10.1093\/cid\/ciaa1177"},{"key":"1551_CR115","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1001\/jama.1994.03510470040032","volume":"271","author":"CJ Fisher","year":"1994","unstructured":"Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA [Internet]. 1994;271:1836\u201343 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8196140.","journal-title":"JAMA [Internet]"},{"key":"1551_CR116","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med [Internet]. 2016;44:275\u201381 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26584195.","journal-title":"Crit Care Med [Internet]"},{"key":"1551_CR117","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D, et al. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol [Internet]. 2020;2:e325\u201331 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32501454.","journal-title":"Lancet Rheumatol [Internet]"},{"key":"1551_CR118","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/S2665-9913(20)30167-3","volume":"2","author":"C Ucciferri","year":"2020","unstructured":"Ucciferri C, Auricchio A, Di Nicola M, Potere N, Abbate A, Cipollone F, et al. Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol [Internet]. 2020;2:e457\u2013ee458 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32835251.","journal-title":"Lancet Rheumatol [Internet]"},{"key":"1551_CR119","unstructured":"\u2022\u2022 Cremer PC, Sheng C, Sahoo D, Dugar S, Aguillon-Prada R, Hernandez-Montfort J, et al. Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function in Sars-cov2 Associated Myocardial Injury With Heightened Inflammation (canakinumab in Covid-19 Cardiac Injury): Results From the Randomized Three C Study. Late-Breaking. Sci Abstr Featur Sci Abstr From Am Hear Assoc Sci Sess 2020 [Internet]. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000940. In patients with cardiac injury, this study showed that patients with high dose canakinumab were numerically more likely to demonstrate clinical recovery at 28 days."},{"key":"1551_CR120","doi-asserted-by":"publisher","unstructured":"Malgie J, Schoones JW, Pijls BG. Decreased mortality in coronavirus disease 2019 patients treated with tocilizumab: a rapid systematic review and meta-analysis of observational studies. Clin Infect Dis. 2021 Jun 1;72(11):e742\u20139. https:\/\/doi.org\/10.1093\/cid\/ciaa1445.","DOI":"10.1093\/cid\/ciaa1445"},{"key":"1551_CR121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, et al. Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. JAMA Intern Med [Internet]. 2021;181:41\u201351 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33080002.","journal-title":"JAMA Intern Med [Internet]"},{"key":"1551_CR122","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","volume":"383","author":"JH Stone","year":"2020","unstructured":"Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, et al. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. N Engl J Med [Internet]. 2020;383:2333\u201344 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33085857.","journal-title":"N Engl J Med [Internet]"},{"key":"1551_CR123","unstructured":"The REMAP-CAP Investigators. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 \u2013 Preliminary report. Unpubl Work. 2021;"},{"key":"1551_CR124","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jama.2020.10044","volume":"324","author":"L Li","year":"2020","unstructured":"Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang J, et al. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial. JAMA [Internet]. 2020;324:460\u201370 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32492084.","journal-title":"JAMA [Internet]"},{"key":"1551_CR125","doi-asserted-by":"publisher","first-page":"m3939","DOI":"10.1136\/bmj.m3939","volume":"371","author":"A Agarwal","year":"2020","unstructured":"Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P, et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial). BMJ [Internet]. 2020;371:m3939 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33093056.","journal-title":"BMJ [Internet]"},{"key":"1551_CR126","doi-asserted-by":"crossref","unstructured":"Joyner MJ, Senefeld JW, Klassen SA, Mills JR, Johnson PW, Theel ES, et al. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. medRxiv Prepr Serv Heal Sci [Internet]. 2020; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32817978.","DOI":"10.1101\/2020.08.12.20169359"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-021-01551-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-021-01551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T09:55:30Z","timestamp":1672998930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-021-01551-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":126,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1551"],"URL":"https:\/\/doi.org\/10.1007\/s11886-021-01551-x","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"11 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"Dr. Wang reports grants from National Heart Foundation of New Zealand, outside the submitted work.Dr. Cremer reports grants from Novartis Pharmaceuticals and Kiniksa Pharmaceuticals; and personal fees from Kiniksa Pharmaceuticals and Sobi Pharmaceuticals, outside the submitted work.The other authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"129"}}